Concepts (55)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Burkholderia Infections | 1 | 2020 | 4 | 0.730 |
Why?
|
| Antimicrobial Stewardship | 1 | 2020 | 33 | 0.700 |
Why?
|
| Pseudomonas Infections | 1 | 2020 | 83 | 0.680 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2020 | 98 | 0.670 |
Why?
|
| Cystic Fibrosis | 2 | 2020 | 283 | 0.630 |
Why?
|
| Hearing Loss | 1 | 2020 | 154 | 0.610 |
Why?
|
| Guanylate Cyclase | 1 | 2015 | 25 | 0.510 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2015 | 66 | 0.490 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 767 | 0.470 |
Why?
|
| Pyrazoles | 1 | 2015 | 190 | 0.460 |
Why?
|
| Pyrimidines | 1 | 2015 | 178 | 0.460 |
Why?
|
| Hypertension, Pulmonary | 1 | 2015 | 232 | 0.410 |
Why?
|
| Eosinophilia | 1 | 2007 | 47 | 0.280 |
Why?
|
| Pleural Effusion | 1 | 2007 | 74 | 0.280 |
Why?
|
| Valproic Acid | 1 | 2007 | 93 | 0.280 |
Why?
|
| Guidelines as Topic | 1 | 2020 | 123 | 0.180 |
Why?
|
| Sarcoidosis, Pulmonary | 2 | 2010 | 17 | 0.180 |
Why?
|
| Patients | 1 | 2020 | 69 | 0.170 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2010 | 186 | 0.160 |
Why?
|
| Health Personnel | 1 | 2020 | 286 | 0.150 |
Why?
|
| Soluble Guanylyl Cyclase | 1 | 2015 | 5 | 0.130 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2015 | 84 | 0.120 |
Why?
|
| Surveys and Questionnaires | 2 | 2020 | 2800 | 0.110 |
Why?
|
| Tobramycin | 1 | 2012 | 38 | 0.110 |
Why?
|
| Humans | 8 | 2020 | 68618 | 0.100 |
Why?
|
| Critical Illness | 1 | 2011 | 191 | 0.090 |
Why?
|
| Delphi Technique | 1 | 2010 | 62 | 0.090 |
Why?
|
| Dietary Supplements | 1 | 2011 | 332 | 0.080 |
Why?
|
| Male | 5 | 2020 | 37321 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2012 | 1026 | 0.070 |
Why?
|
| Female | 4 | 2020 | 38074 | 0.050 |
Why?
|
| Drug Administration Schedule | 2 | 2010 | 567 | 0.040 |
Why?
|
| Adult | 3 | 2012 | 21403 | 0.030 |
Why?
|
| Veins | 1 | 2012 | 68 | 0.030 |
Why?
|
| Administration, Inhalation | 1 | 2012 | 187 | 0.030 |
Why?
|
| Drug Monitoring | 1 | 2012 | 107 | 0.030 |
Why?
|
| Probiotics | 1 | 2011 | 14 | 0.020 |
Why?
|
| Fish Oils | 1 | 2011 | 21 | 0.020 |
Why?
|
| Androgens | 1 | 2011 | 41 | 0.020 |
Why?
|
| Dietary Fiber | 1 | 2011 | 37 | 0.020 |
Why?
|
| Education, Continuing | 1 | 2011 | 28 | 0.020 |
Why?
|
| Glutamine | 1 | 2011 | 45 | 0.020 |
Why?
|
| Selenium | 1 | 2011 | 36 | 0.020 |
Why?
|
| Zinc | 1 | 2011 | 73 | 0.020 |
Why?
|
| Arginine | 1 | 2011 | 102 | 0.020 |
Why?
|
| Respiratory Function Tests | 1 | 2010 | 123 | 0.020 |
Why?
|
| Consensus | 1 | 2010 | 211 | 0.020 |
Why?
|
| Acute Disease | 1 | 2010 | 658 | 0.020 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2010 | 504 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 3259 | 0.010 |
Why?
|
| Young Adult | 1 | 2012 | 5717 | 0.010 |
Why?
|
| Time Factors | 1 | 2010 | 4655 | 0.010 |
Why?
|
| Adolescent | 1 | 2012 | 8912 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2010 | 7277 | 0.010 |
Why?
|
| Middle Aged | 1 | 2010 | 21147 | 0.010 |
Why?
|